Clinical trial
Comparison of Dendritic Cells Versus Montanide as Adjuvants in a Melanoma…
NCT00124124 · Dr. Nina Bhardwaj, Other · Completed
Key facts
| NCT number | NCT00124124 |
|---|---|
| Title | Comparison of Dendritic Cells Versus Montanide as Adjuvants in a Melanoma Vaccine |
| Official title | A Randomized, Controlled Trial of Melanoma Treatment: Comparison of Dendritic Cells Versus Montanide as Adjuvants to Stimulate Anti-tumor Immunity |
| Lead sponsor | Dr. Nina Bhardwaj, Other |
| Collaborators | Cancer Research Institute, New York City |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Melanoma |
| Intervention type | Drug |
| Interventions | KLH, Peptides, Dendritic Cells, peptides plus Montanide |
| Enrollment | 50 |
| Start date | Jul 1, 2005 |
| Primary completion | Jul 1, 2008 |
| Completion | Apr 1, 2009 |
| First posted | Jul 27, 2005 |
| Last update posted | Feb 13, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: